Wolverine Blend (BPC-157 + TB-500) 50mg — Vial Spec, Reconstitution Math & COA

Overview & Specification of the 50mg Wolverine Blend Vial

A 50mg vial of the wolverine blend (bpc-157 + tb-500) 50mg represents a high-capacity dual-peptide research compound engineered for extensive, multi-well in vitro assays and longitudinal preclinical studies. In standard formulations, this 50mg total lyophilized mass contains an equal ratio of two synthetic peptides: 25mg of Body Protection Compound 157 (BPC-157) and 25mg of Thymosin Beta-4 synthetic fragment (TB-500). High-mass vials of this specification are primarily ordered by high-throughput screening facilities, academic biochemical research laboratories, and institutional investigators running large sample cohorts where maintaining single-lot consistency across extended experimental timelines is paramount to control for inter-batch variability.

It is important to clarify catalog availability for institutional purchasing departments: PX1 Research maintains standard stock in smaller formats, such as our popular 10mg Wolverine Blend (5mg BPC-157 / 5mg TB-500). For researchers requiring 50mg bulk fills or custom high-mass lots to support high-throughput automated platforms, specialized procurement can be arranged directly. Investigators are encouraged to review our full catalog of research peptides to select the exact fill volume suited to their experimental design.

Molecular Profiles & Synergistic Preclinical Mechanisms

The Wolverine Blend combines two distinct peptides that target non-overlapping cellular pathways involved in tissue remodeling, cell migration, and structural synthesis. BPC-157 is a stable 15-amino acid pentadecapeptide derived from human gastric juice protein sequences. Preclinical studies suggest that BPC-157 upregulates growth factor expression, including vascular endothelial growth factor (VEGF) and focal adhesion kinase (FAK), promoting microvascular tube formation and cell survival under hypoxic in vitro conditions.

Conversely, TB-500 is a synthetic short-chain peptide corresponding to the active G-actin binding domain (Ac-SDKP) of naturally occurring Thymosin Beta-4. In vitro data indicate that TB-500 regulates monomeric actin sequestering, facilitating rapid cell motility, cytoskeletal reorganization, and endothelial cell migration into damaged cellular matrices. When combined into a single 50mg research matrix, these compounds allow investigators to examine potential synergistic signaling cascades—specifically how simultaneous actin-mediated cell migration (TB-500) and angiogenic expression pathways (BPC-157) alter cellular repair kinetics in wound healing assays and musculoskeletal cell cultures.

Reconstitution Math for 50mg High-Mass Vials

Reconstituting a 50mg high-density lyophilized mass requires precise volumetric calculations to achieve target stock concentrations while ensuring full solubilization. Because the total mass is significantly higher than standard 5mg or 10mg single-use vials, larger diluent volumes or adjusted aliquot protocols are typically necessary. Researchers must account for total volume displacement and solution viscosity when working with high concentration stocks.

To calculate working concentrations for a 50mg (25mg BPC-157 / 25mg TB-500) vial across standard laboratory diluent volumes:

• 1.0 mL Diluent Volume: Adding 1.0 mL of reconstituting solvent yields a total compound concentration of 50.0 mg/mL (25.0 mg/mL BPC-157 and 25.0 mg/mL TB-500). Each 10 µL micro-aliquot contains 500 µg total compound (250 µg per peptide).

• 2.0 mL Diluent Volume: Adding 2.0 mL of diluent yields a total compound concentration of 25.0 mg/mL (12.5 mg/mL BPC-157 and 12.5 mg/mL TB-500). Each 10 µL micro-aliquot contains 250 µg total compound (125 µg per peptide).

• 3.0 mL Diluent Volume: Adding 3.0 mL of diluent yields a total compound concentration of 16.67 mg/mL (8.33 mg/mL BPC-157 and 8.33 mg/mL TB-500). Each 10 µL micro-aliquot contains 166.7 µg total compound (83.3 µg per peptide).

To easily model custom concentration thresholds or calculate micro-liter pipette volumes for specific assay wells, laboratory personnel should utilize the PX1 interactive reconstitution calculator.

Laboratory Aliquoting & Solvent Selection Strategy

Because a 50mg vial contains a substantial quantity of active material intended for multi-day or multi-week assay schedules, maintaining reconstituted peptide stability is critical. Reconstituting the entire 50mg mass in a single master vial and repeatedly piercing the septum introduces risk of atmospheric oxidation, evaporation, and bacterial contamination. Furthermore, repeated freeze-thaw cycles degrade the peptide chain integrity through mechanical shear forces caused by ice crystal formation.

The standard laboratory protocol for high-mass vials involves immediate post-reconstitution aliquoting. After reconstituting the lyophilized cake with sterile Bacteriostatic Water (0.9% benzyl alcohol preserved) or Sterile Normal Saline, the stock solution should be immediately divided into single-use polypropylene micro-centrifuge tubes (e.g., 50 µL to 200 µL working volumes). These working aliquots are then flash-frozen and stored at -20°C or -80°C. Individual sub-aliquots are thawed only once immediately prior to addition to cell culture media or microfluidic testing apparatuses.

Analytical Quality Assurance: HPLC, Mass Spectrometry & COAs

PX1 Research enforces strict quality control standards for all synthetic peptides. Every batch of Wolverine Blend undergoes rigorous analytical validation prior to release, ensuring that institutional researchers receive compounds of absolute purity and consistent identity.

Quality verification involves two primary analytical techniques performed in our ISO 17025 accredited laboratory environment:

1. High-Performance Liquid Chromatography (HPLC): Confirms chemical purity. PX1 guarantees target peptide purity exceeding 99.0%, ensuring that micro-quantities of truncated synthesis byproducts or organic impurities do not interfere with sensitive receptor binding or gene expression studies.

2. Liquid Chromatography-Mass Spectrometry (LC-MS): Verifies exact molecular mass. Mass spectra confirm the structural identity of both BPC-157 (molecular weight ~1419.5 Da) and TB-500 (molecular weight ~496.5 Da for the active domain fragment).

In addition to purity and identity testing, every production fill is subjected to Chromogenic Limulus Amebocyte Lysate (LAL) assays to confirm endotoxin levels remain strictly below <0.05 EU/mg. Institutional researchers can inspect complete, lot-matched analytical documentation directly via the PX1 online COA lookup portal.

Storage Stability Protocols for High-Mass Lyophilized Vials

Proper storage conditions are mandatory to prevent premature peptide hydrolysis or aggregation over long storage windows. Prior to reconstitution, unopened 50mg Wolverine Blend vials containing dry lyophilized cake should be stored in a dark, desiccated freezer environment maintained between -20°C and -80°C. Under these sub-zero, moisture-controlled conditions, the chemical integrity of the peptide backbone remains stable for up to 24 months.

Once liquid diluent is introduced, reconstituted peptide solutions must be kept refrigerated at 2°C to 8°C if intended for immediate use within 48 to 72 hours. For extended assay series spanning weeks or months, aliquoted liquid stocks must be frozen at -20°C or colder. Light exposure should be minimized by utilizing amber storage vials or opaque storage boxes, as ultraviolet radiation can accelerate photo-oxidation of vulnerable amino acid residues within the peptide sequence.

Comparative Analysis: Dual-Peptide Blends vs. Single-Target Compounds

In preclinical model design, selecting between single-target peptides and co-formulated blends depends on the specific biological pathways under evaluation. While single-target research compounds allow investigators to isolate specific receptor dynamics, dual formulations like the Wolverine Blend provide a pre-formulated platform to observe concurrent intracellular cascades.

When evaluating tissue matrix research, investigators frequently compare the Wolverine Blend against individual compounds. For instance, studying isolated endothelial migration often involves standalone BPC-157, whereas actin dynamics are specifically examined using standalone TB-500. In inflammatory extracellular matrix models, alternative single compounds such as KPV target NF-κB inflammatory pathways without direct angiogenic involvement, while GHK-Cu introduces copper-modulated gene transcription for collagen synthesis. Evaluating the Wolverine Blend alongside these individual compounds allows research teams to map complex multi-pathway responses in tissue regeneration assays.

Determining Optimal Vial Formulations for High-Throughput Assays

Selecting between standard 10mg vials and enterprise-level 50mg vials depends on institutional protocol requirements, liquid handling automation, and project duration. While smaller 10mg vials (5mg BPC-157 / 5mg TB-500) are optimal for pilot studies, exploratory bench research, or short-term animal model assays, high-mass 50mg formats excel in high-throughput screening environments.

Utilizing a single 50mg master lot for an extended study eliminates batch-to-batch variance across experimental replicates. Automation platforms and robotic liquid handlers benefit from working with centralized stock solutions reconstituted from a single high-capacity vial. Institutional laboratories planning high-volume research trials or bulk procurement can explore dedicated account options through the PX1 wholesale portal.

In Vitro Handling & Aseptic Reconstitution Best Practices

To maintain absolute purity and prevent solution degradation during initial reconstitution, research personnel must adhere to strict aseptic techniques within a certified laminar flow biosafety cabinet:

1. Sanitization: Thoroughly wipe the rubber stopper of the 50mg vial with 70% isopropyl alcohol and allow it to air-dry completely.

2. Diluent Entry: Use a sterile needle and syringe to draw the exact volume of Bacteriostatic Water or Saline. Direct the needle tip toward the inner glass wall of the vial rather than shooting directly onto the delicate lyophilized cake.

3. Solubilization: Allow the liquid to slowly stream down the glass wall. Gently swirl the vial in a circular motion until the lyophilized cake fully dissolves. Never subject reconstituted peptide solutions to vigorous shaking or high-speed vortexing, as mechanical agitation can denature the tertiary structure.

4. Inspection: Visually inspect the solution. The reconstituted liquid must appear completely clear, colorless, and free of visible particulate matter prior to assay introduction.

For additional laboratory protocols, solubilization guides, and analytical documentation, visit the comprehensive PX1 Research Library.